Cogent Biosciences | ARS: Annual Report to Security Holders
Cogent Biosciences | DEFA14A: Others
Cogent Biosciences | DEF 14A: Definitive information statements
Cogent Biosciences | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Cogent Biosciences | EFFECT: Others
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Ferrante Karen Jean
Cogent Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(9.90%),Fairmount Healthcare Fund II GP LLC(9.90%), etc.
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-Director Fairmount Funds Management LLC
Cogent Biosciences | S-3: Registration statement for specified transactions by certain issuers
Cogent Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(9.90%),Fairmount Healthcare Fund II GP LLC(9.90%), etc.
Cogent Biosciences | 8-K: Current report
Cogent Biosciences | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Cogent Biosciences | 10-K: Annual report
Cogent Biosciences | 8-K: Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
Cogent Biosciences | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Fairmount Funds Management LLC(18.89%),Fairmount Healthcare Fund II GP LLC(15.99%), etc.
Cogent Biosciences | 4: Statement of changes in beneficial ownership of securities-10% Owner Fairmount Funds Management LLC
Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Venrock Healthcare Capital Partners II, L.P.(9.99%),VHCP Co-Investment Holdings II, LLC(9.99%), etc.
Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(7.1%),Commodore Capital Master LP(7.1%)
Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-RA Capital Management, L.P.(0%),Peter Kolchinsky(0%), etc.
Cogent Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Steven A. Cohen(6.1%),Point72 Asset Management, L.P.(6.0%), etc.
No Data